The Valsalva maneuver: screening for drug-induced baroreflex dysfunction

Area of Science:

• Pharmacology
• Cardiovascular Physiology
• Autonomic Nervous System

Background:

• Many medications can disrupt baroreflex mechanisms, impacting blood pressure regulation.
• A lack of simple, cost-effective screening tests hinders the assessment of drug-induced baroreflex dysfunction.

Purpose of the Study:

• To evaluate the Valsalva maneuver's utility in detecting drug-induced alterations in baroreflex function.
• To determine if a simple Valsalva maneuver can identify changes previously observed with complex methods.

Main Methods:

• Eleven healthy males participated in a placebo-controlled, double-blind, randomized crossover study.
• The Valsalva maneuver was performed after pharmacological inhibition of the norepinephrine transporter (NET).
• Patients with severe autonomic failure served as positive controls.

Main Results:

• Norepinephrine transporter inhibition significantly increased blood pressure decrease during phase II of the Valsalva maneuver.
• Norepinephrine transporter inhibition attenuated the blood pressure overshoot during phase IV.
• Heart rate response during the Valsalva maneuver was amplified following norepinephrine transporter inhibition.

Conclusions:

• The Valsalva maneuver accurately reflects baroreflex regulation changes induced by norepinephrine transporter inhibition.
• This straightforward and economical test can serve as a screening tool for drug-induced baroreflex impairment.